Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innospec (IOSP) EBT (2016 - 2025)

Innospec's EBT history spans 16 years, with the latest figure at -$51.8 million for Q4 2025.

  • For Q4 2025, EBT rose 3.36% year-over-year to -$51.8 million; the TTM value through Dec 2025 reached $37.7 million, down 58.2%, while the annual FY2025 figure was $25.9 million, 71.29% down from the prior year.
  • EBT for Q4 2025 was -$51.8 million at Innospec, down from $8.1 million in the prior quarter.
  • Across five years, EBT topped out at $55.3 million in Q1 2024 and bottomed at -$53.6 million in Q4 2024.
  • The 5-year median for EBT is $41.2 million (2021), against an average of $27.1 million.
  • The largest annual shift saw EBT skyrocketed 174.54% in 2021 before it crashed 175.0% in 2023.
  • A 5-year view of EBT shows it stood at $32.7 million in 2021, then skyrocketed by 38.23% to $45.2 million in 2022, then plummeted by 175.0% to -$33.9 million in 2023, then plummeted by 58.11% to -$53.6 million in 2024, then increased by 3.36% to -$51.8 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's EBT are -$51.8 million (Q4 2025), $8.1 million (Q3 2025), and $37.0 million (Q2 2025).